4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001013762-23-001297
Chief Executive Officer acquired 3,167,554 shares (conversion)
- Chief Executive Officer returned 3,167,554 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Santos da Silva Jorge Chief Executive Officer | 2023-10-01 | Conversion | +3,027,483 | 3,027,483 | D: show line 1 in the form | ||
| Santos da Silva Jorge Chief Executive Officer | 2023-10-01 | Returned to the company | −3,027,483 | 0 | D: show line 2 in the form | ||
| Santos da Silva Jorge Chief Executive Officer | 2023-10-01 | Conversion | +140,071 | 3,167,554 | D: show line 3 in the form | ||
| Santos da Silva Jorge Chief Executive Officer | 2023-10-01 | Returned to the company | −140,071 | 217,374 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Santos da Silva Jorge Chief Executive Officer | 2023-10-01 | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −90,000 | 0 | D: show line 5 in the form | ||
| Santos da Silva Jorge Chief Executive Officer | 2023-10-01 | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −4,164 | 5,836 | D: show line 6 in the form |
Loading xslF345X05/ownership.xml…